2Schoemaker H, Claustre Y, Fage Dr et al. Neurochemieal characteristics of Amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbie selectivity[ J ]. The Journal of Pharmacology and Experimental Therapeutics, 1997, 280 : 83 - 97.
3Leucht S, Corves C, Arbter D, et al. Second-generation versus first-generation antipsychotie drugs for schizophrenia: a meta-analysis[ J ]. Lancet JT-Lancet, 2009,373 (9657) : 31 -41.
4Meisenzahl EM, Schmitt G, Grunder G, et al, Striatal DJ D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study [ J]. Pharmacopsychiatry, 2008,41 (5) : 169 - 175.
